FDA Compliance

RollerTec produces flexo rubber roller materials that we label FDA compounds.  The FDA does not specifically approve rubber compounds.  The FDA, in Title 21, Part 177.2600 of the Code of Federal Regulations, specifies rubber compound ingredients that are considered to be non-toxic and non-carcinogenic when used in the amounts specified.  Compounds must also pass the extraction tests outlined by the FDA.

Materials meeting these requirements are said to "meet the requirements of the FDA".  Each of the compounds shown here is formulated with materials sanctioned under the FDA Code of Federal Regulations, Title 21, Part 177.2600. Contact  RollerTec Inc. for additional FDA compliant rubber materials.